Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats

Mark S. Todtenkopf, Jacqueline F. Marcus, Philip S Portoghese, William A. Carlezon

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

Rationale: Elevations in cAMP response element binding protein (CREB) function within the mesolimbic system of rats reduce cocaine reward in place conditioning studies and increase immobility in the forced swim test. Each of these behavioral adaptations can be interpreted as a depressive-like effect (i.e., anhedonia, despair) that may reflect reduced activity of brain reward systems. Furthermore, each effect appears due to increases in CREB-mediated expression of dynorphin, since each is attenuated by intracranial injections of the κ-opioid receptor antagonist norBNI. Objectives: Intracranial self-stimulation (ICSS) studies were conducted in rats to determine whether administration of a κ-agonist would have depressive-like effects on brain stimulation reward, and whether pretreatment with a κ-antagonist would attenuate any such effects. Conditions that have depressive effects in people (e.g., drug withdrawal) increase the threshold amounts of stimulation required to sustain ICSS in rats. Methods: Sprague-Dawley rats with lateral hypothalamic stimulating electrodes were tested in a "curve-shift" variant of the ICSS procedure after systemic administration of the κ-agonist U-69593 alone, the novel κ-antagonist 5′-acetamidinoethylnaltrindole (ANTI) alone, or co-administration of both drugs. Results: U-69593 dose dependently increased ICSS thresholds, suggesting that activation of κ-receptors reduced the rewarding impact of the brain stimulation. ANTI had no effects on its own, but it attenuated increases in ICSS thresholds caused by the agonist. Conclusions: These data provide further evidence that stimulation of brain κ-receptors may trigger certain depressive-like signs, and that κ antagonists may have efficacy as antidepressants without having reward-related actions of their own.

Original languageEnglish (US)
Pages (from-to)463-470
Number of pages8
JournalPsychopharmacology
Volume172
Issue number4
DOIs
StatePublished - Apr 1 2004

Fingerprint

Self Stimulation
Opioid Receptors
Reward
Ligands
Cyclic AMP Response Element-Binding Protein
Brain
Anhedonia
Dynorphins
Narcotic Antagonists
Cocaine
Pharmaceutical Preparations
Antidepressive Agents
Sprague Dawley Rats
Electrodes
Injections

Keywords

  • Brain stimulation reward
  • CREB
  • Depression
  • Dynorphin
  • Dysphoria
  • Kappa

Cite this

Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats. / Todtenkopf, Mark S.; Marcus, Jacqueline F.; Portoghese, Philip S; Carlezon, William A.

In: Psychopharmacology, Vol. 172, No. 4, 01.04.2004, p. 463-470.

Research output: Contribution to journalArticle

Todtenkopf, Mark S. ; Marcus, Jacqueline F. ; Portoghese, Philip S ; Carlezon, William A. / Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats. In: Psychopharmacology. 2004 ; Vol. 172, No. 4. pp. 463-470.
@article{e55fa71c3d9b427ba54f85564bcf4782,
title = "Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats",
abstract = "Rationale: Elevations in cAMP response element binding protein (CREB) function within the mesolimbic system of rats reduce cocaine reward in place conditioning studies and increase immobility in the forced swim test. Each of these behavioral adaptations can be interpreted as a depressive-like effect (i.e., anhedonia, despair) that may reflect reduced activity of brain reward systems. Furthermore, each effect appears due to increases in CREB-mediated expression of dynorphin, since each is attenuated by intracranial injections of the κ-opioid receptor antagonist norBNI. Objectives: Intracranial self-stimulation (ICSS) studies were conducted in rats to determine whether administration of a κ-agonist would have depressive-like effects on brain stimulation reward, and whether pretreatment with a κ-antagonist would attenuate any such effects. Conditions that have depressive effects in people (e.g., drug withdrawal) increase the threshold amounts of stimulation required to sustain ICSS in rats. Methods: Sprague-Dawley rats with lateral hypothalamic stimulating electrodes were tested in a {"}curve-shift{"} variant of the ICSS procedure after systemic administration of the κ-agonist U-69593 alone, the novel κ-antagonist 5′-acetamidinoethylnaltrindole (ANTI) alone, or co-administration of both drugs. Results: U-69593 dose dependently increased ICSS thresholds, suggesting that activation of κ-receptors reduced the rewarding impact of the brain stimulation. ANTI had no effects on its own, but it attenuated increases in ICSS thresholds caused by the agonist. Conclusions: These data provide further evidence that stimulation of brain κ-receptors may trigger certain depressive-like signs, and that κ antagonists may have efficacy as antidepressants without having reward-related actions of their own.",
keywords = "Brain stimulation reward, CREB, Depression, Dynorphin, Dysphoria, Kappa",
author = "Todtenkopf, {Mark S.} and Marcus, {Jacqueline F.} and Portoghese, {Philip S} and Carlezon, {William A.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1007/s00213-003-1680-y",
language = "English (US)",
volume = "172",
pages = "463--470",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats

AU - Todtenkopf, Mark S.

AU - Marcus, Jacqueline F.

AU - Portoghese, Philip S

AU - Carlezon, William A.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Rationale: Elevations in cAMP response element binding protein (CREB) function within the mesolimbic system of rats reduce cocaine reward in place conditioning studies and increase immobility in the forced swim test. Each of these behavioral adaptations can be interpreted as a depressive-like effect (i.e., anhedonia, despair) that may reflect reduced activity of brain reward systems. Furthermore, each effect appears due to increases in CREB-mediated expression of dynorphin, since each is attenuated by intracranial injections of the κ-opioid receptor antagonist norBNI. Objectives: Intracranial self-stimulation (ICSS) studies were conducted in rats to determine whether administration of a κ-agonist would have depressive-like effects on brain stimulation reward, and whether pretreatment with a κ-antagonist would attenuate any such effects. Conditions that have depressive effects in people (e.g., drug withdrawal) increase the threshold amounts of stimulation required to sustain ICSS in rats. Methods: Sprague-Dawley rats with lateral hypothalamic stimulating electrodes were tested in a "curve-shift" variant of the ICSS procedure after systemic administration of the κ-agonist U-69593 alone, the novel κ-antagonist 5′-acetamidinoethylnaltrindole (ANTI) alone, or co-administration of both drugs. Results: U-69593 dose dependently increased ICSS thresholds, suggesting that activation of κ-receptors reduced the rewarding impact of the brain stimulation. ANTI had no effects on its own, but it attenuated increases in ICSS thresholds caused by the agonist. Conclusions: These data provide further evidence that stimulation of brain κ-receptors may trigger certain depressive-like signs, and that κ antagonists may have efficacy as antidepressants without having reward-related actions of their own.

AB - Rationale: Elevations in cAMP response element binding protein (CREB) function within the mesolimbic system of rats reduce cocaine reward in place conditioning studies and increase immobility in the forced swim test. Each of these behavioral adaptations can be interpreted as a depressive-like effect (i.e., anhedonia, despair) that may reflect reduced activity of brain reward systems. Furthermore, each effect appears due to increases in CREB-mediated expression of dynorphin, since each is attenuated by intracranial injections of the κ-opioid receptor antagonist norBNI. Objectives: Intracranial self-stimulation (ICSS) studies were conducted in rats to determine whether administration of a κ-agonist would have depressive-like effects on brain stimulation reward, and whether pretreatment with a κ-antagonist would attenuate any such effects. Conditions that have depressive effects in people (e.g., drug withdrawal) increase the threshold amounts of stimulation required to sustain ICSS in rats. Methods: Sprague-Dawley rats with lateral hypothalamic stimulating electrodes were tested in a "curve-shift" variant of the ICSS procedure after systemic administration of the κ-agonist U-69593 alone, the novel κ-antagonist 5′-acetamidinoethylnaltrindole (ANTI) alone, or co-administration of both drugs. Results: U-69593 dose dependently increased ICSS thresholds, suggesting that activation of κ-receptors reduced the rewarding impact of the brain stimulation. ANTI had no effects on its own, but it attenuated increases in ICSS thresholds caused by the agonist. Conclusions: These data provide further evidence that stimulation of brain κ-receptors may trigger certain depressive-like signs, and that κ antagonists may have efficacy as antidepressants without having reward-related actions of their own.

KW - Brain stimulation reward

KW - CREB

KW - Depression

KW - Dynorphin

KW - Dysphoria

KW - Kappa

UR - http://www.scopus.com/inward/record.url?scp=2442628167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442628167&partnerID=8YFLogxK

U2 - 10.1007/s00213-003-1680-y

DO - 10.1007/s00213-003-1680-y

M3 - Article

VL - 172

SP - 463

EP - 470

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 4

ER -